If you are using semaglutide or tirzepatide as part of a clinician-directed weight-management plan, this guide addresses a question the scale cannot answer: how can you keep the focus on fat loss, lean tissue, and function? It covers body composition during GLP-1-supported weight management, resistance training and protein, the creatine evidence base, and the practical limits of that evidence.

 

Quick Answer: Can You Protect Lean Mass During GLP-1 Weight Loss?

 

GLP-1-supported weight loss can involve reductions in both fat mass and lean tissue. Resistance training, individualized protein planning, and appropriate monitoring are the higher-priority conversations. Creatine has evidence for supporting muscle and exercise performance alongside training in general populations, but no study cited here tests Creatine Reserve™ for lean-mass preservation during GLP-1 therapy.

One boundary belongs up front because it frames everything below: Creatine Reserve™ has not been studied to preserve lean mass during GLP-1 therapy. No trial cited in this article has tested this finished formula in people using a GLP-1 medication. What follows is source-led education and an honest description of the product, so you and your clinician can decide whether it belongs in your plan.

The Problem: Why Body Composition Deserves Attention on GLP-1 Medications

 

Weight loss can reduce both fat mass and lean tissue, although the mix varies by the person, the intervention, training, protein intake, and how body composition is measured.

In the STEP 1 semaglutide trial’s DXA substudy, both fat mass and lean body mass decreased over 68 weeks, with the percentage reduction in fat mass larger than the percentage reduction in lean body mass. Among the 95 semaglutide participants in the substudy, total fat mass changed by -19.3% and total lean body mass by -9.7%. The exploratory analysis also found that lean mass represented a larger proportion of total body mass after treatment.

Two caveats matter before you read too much into those numbers. DXA lean tissue is not the same as pure skeletal muscle: it also reflects water and other non-fat tissue. And the STEP 1 data come from a subgroup, so they should not be treated as the guaranteed experience of every GLP-1 user.

Lean tissue contributes to strength, physical function, and metabolic health, which is why body composition can matter as much as the number on the scale. Clinical discussions commonly emphasize resistance training, individualized protein planning, and monitoring when appropriate, with supplements considered case by case. A 2025 GLP-1 narrative review similarly discusses protein, resistance training, and selected supplements in the broader context of GLP-1 receptor agonist treatment.

The practical foundation is not glamorous: train consistently, plan protein with your clinician or qualified nutrition professional when needed, and pay attention to function and body composition rather than the scale alone. A supplement can be a supporting tool around those habits, not a replacement for them.

How to Read Body-Composition Changes Without Overreacting

 

Body-composition data can be useful, but one scan should not become a verdict on whether you are succeeding. DXA and comparable tools estimate fat, lean tissue, and bone measures. They do not directly measure every change in skeletal muscle, and results can be influenced by hydration, food intake, recent exercise, and the equipment used. The most useful question is usually not, “Did one number move?” It is, “What is the trend over time, and does it make sense alongside my strength, function, nutrition, and treatment plan?”

If your clinician recommends repeated body-composition testing, try to keep the conditions as consistent as possible. Use the same type of scan when available, follow the same pre-scan instructions, and avoid comparing a DXA result directly with a home scale or a consumer body-fat estimate as though they measure the same thing. Bring the report to your clinician or qualified professional rather than trying to interpret every line on your own.

It can also help to track practical context between scans. A simple training log, a note about how daily activities feel, and a record of major changes in appetite or protein intake can provide useful conversation points. None of these measures proves that a supplement is working. Together, however, they can help you and your care team see a more complete picture than body weight alone.

What Creatine Reserve™ Is

 

Creatine Reserve™ is a multi-ingredient creatine powder developed by Triquetra Health for adults combining resistance training with GLP-1-supported weight management who want creatine, its precursor GAA, and selected B-vitamin forms in one daily scoop.

One scoop, about 10 g, provides:

·       Creatine monohydrate, 5,000 mg

·       Guanidinoacetic acid, or GAA, 1,000 mg

·       Taurine, 1,500 mg

·       L-methylfolate, 5-MTHF calcium salt, 400 μg DFE

·       Methylcobalamin, 1,000 μg

·       Pyridoxal-5-phosphate, or P5P, 20 mg

Creatine monohydrate is among the most researched supplements for supporting muscle and exercise performance alongside resistance training.* Creatine Reserve™ combines creatine itself with GAA, a natural precursor the body converts into creatine. The finished formula has not been studied to preserve lean mass during GLP-1 therapy. The sections below describe what research on the individual ingredients and related combinations shows, and where that evidence stops.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

The Mechanism, Explained Plainly

 

During short, high-intensity efforts, muscles rely in part on the phosphocreatine system to rapidly regenerate ATP, the energy molecule used for muscular work. Creatine is involved in that system, which helps explain why creatine monohydrate is one of the most researched ergogenic supplements in sports nutrition.

Guanidinoacetic acid, or GAA, is the molecule the body uses to make creatine. Combining creatine with GAA is sometimes described as a dual-pathway approach because the formula supplies creatine directly while also including its precursor. Small human studies have examined this combination, but those studies are not studies of Creatine Reserve™ or GLP-1 users.

A plausible biological pathway is a reason to investigate an ingredient, not proof of a real-world outcome. Mechanism alone does not establish that a given formula improves training, body composition, or outcomes in people using GLP-1 medication. It is the reason research is worth doing, not a promise of what a product will do.

 

What the Research Shows, and Its Limits

 

Here is the evidence base with the population and dose placed next to each finding.

Creatine and lean mass in general populations

A 2024 systematic review and meta-analysis of 143 randomized trials, involving approximately 3,655 participants, found a pooled increase in fat-free mass of 0.82 kg with creatine supplementation. The effect was more robust when creatine was paired with resistance or combined training. Pashayee-Khamene et al. pooled general-population research. It was not a study of this formula or of people using GLP-1 medication.

In adults aged 57 to 70, a separate meta-analysis of 22 trials involving 721 participants reported a 1.37 kg increase in lean tissue mass with creatine plus resistance training. Chilibeck et al. also evaluated general older-adult populations, not GLP-1 users and not a finished multi-ingredient product.

The creatine-plus-GAA combination

In one four-week study of 14 healthy young men, 1 g GAA plus 3 g creatine produced a larger within-group rise in measured skeletal-muscle creatine than 4 g creatine alone, 16.9% versus 2.0%, as assessed by magnetic resonance spectroscopy. Semeredi et al. was a small, short study in healthy young men and used a 3 g creatine plus 1 g GAA ratio, not this formula’s 5 g plus 1 g.

In a separate six-week study of 66 healthy recreationally active adults, 10 g creatine monohydrate with or without 2 g GAA did not produce adverse changes in the clinical blood markers assessed, including homocysteine. Babakhani et al. provides short-term marker data in healthy adults. It is not an efficacy study, a GLP-1 study, a lean-mass study, or a study of this formula.

The GLP-1 connection

A 2025 narrative review in Obesity Pillars discusses creatine monohydrate in the GLP-1 context and notes additional strength benefits when it is paired with resistance training. The review is a synthesis of existing literature, not a clinical trial of creatine, GAA, or any finished formula in GLP-1 users. It does not evaluate the creatine-plus-GAA combination.

That is the honest ceiling on the current evidence: creatine is supported by adjacent research in other populations, but direct clinical evidence for creatine, GAA, or Creatine Reserve™ during GLP-1 therapy is still not established by the studies cited here.

The Metformin and B12 Context

 

Many people using GLP-1 therapy also take metformin, so vitamin B12 comes up often. In the Diabetes Prevention Program Outcomes Study, at year 5, low B12 at or below 203 pg/mL was reported in 4.3% of the metformin group. Combined low or borderline-low B12 at or below 298 pg/mL was reported in 19.1% of the metformin group, compared with 9.9% of the placebo group. Aroda et al. followed participants from the randomized Diabetes Prevention Program into its long-term observational follow-up.

A 2023 real-world database study in people with type 2 diabetes also reported an association between longer metformin use and B12-deficiency laboratory results. The EMBER study is observational and does not establish that any supplement corrects an individual’s B12 status.

The practical takeaway is a referral, not a promise: if you take metformin and have questions about your B12, ask your clinician about testing and clinician-directed care. Creatine Reserve™ supplies vitamin B12 as methylcobalamin. Vitamin B12 supports normal energy metabolism and nervous system function.*

Ingredient by Ingredient

 

Each ingredient is described neutrally, with its role and the limits of what is known.

Creatine monohydrate, 5,000 mg

Creatine monohydrate is the most studied form of creatine in the research cited here and is used to support muscle and exercise performance alongside training.* The formula uses a micronized form for mixability.

Guanidinoacetic acid, or GAA, 1,000 mg

GAA is a natural creatine precursor. It has been evaluated in small human studies in combination with creatine, as described above. It has not been studied in GLP-1 users, and its long-term use is less extensively characterized than creatine’s.

Taurine, 1,500 mg

Taurine is an amino acid found in the body and in foods. It is included as a formula ingredient. Taurine research spans varied populations and doses, none of which establish outcomes for this formula or for GLP-1 users.

L-methylfolate, or 5-MTHF, 400 μg DFE

L-methylfolate is a methylated folate form. It is included as the formula’s folate source. Folate supports normal homocysteine metabolism.*

Methylcobalamin, 1,000 μg

Methylcobalamin is one form of vitamin B12 used in supplements. Vitamin B12 supports normal energy metabolism and nervous system function.*

Pyridoxal-5-phosphate, or P5P, 20 mg

P5P is one form of vitamin B6 used in supplements. Vitamin B6 supports normal homocysteine and energy metabolism.*

Putting these ingredients into one scoop means one product and one daily routine instead of assembling several. That is a format choice, not a claim that the combination outperforms the same ingredients taken separately. That comparison has not been tested.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Questions People Actually Ask

Does GLP-1 weight loss cause muscle loss?

Weight loss with GLP-1 medication can include reductions in both fat mass and lean tissue. In the STEP 1 semaglutide DXA substudy, fat mass and lean body mass both decreased, while the reduction in fat mass was larger. The STEP 1 analysis measured lean body mass, not pure skeletal muscle, so it should not be read as a direct measure of muscle loss. The results also come from a subgroup and should not be generalized to every GLP-1 user.

The practical response is to discuss resistance training, individualized protein planning, and appropriate monitoring with your clinician or qualified nutrition professional. Supplements are a supporting factor around those fundamentals. If you are concerned about strength, function, or body-composition changes during treatment, raise it with your clinician.

Can creatine help preserve muscle during weight loss?

Creatine monohydrate, when paired with resistance training, has evidence for supporting muscle and exercise performance in general populations.* Meta-analyses report modest increases in fat-free or lean mass when creatine is paired with training, including a pooled 0.82 kg increase across 143 randomized trials and a 1.37 kg result in a meta-analysis of older adults. Pashayee-Khamene et al. and Chilibeck et al. did not study people using GLP-1 medications.

No study cited in this article tests creatine specifically for muscle preservation during GLP-1 therapy, and no study cited here tests Creatine Reserve™ for that purpose. Creatine is best viewed as a possible supporting tool around resistance training and protein planning, not as a standalone solution.

What is GAA?

GAA is the molecule the body naturally converts into creatine. Supplementing GAA alongside creatine means supplying creatine directly while also supplying its precursor. In a small four-week study of 14 healthy young men, 1 g GAA plus 3 g creatine raised measured muscle creatine more than 4 g creatine alone. Semeredi et al. used a small sample, a short duration, healthy young men, and a dose ratio that differs from this formula.

GAA’s long-term use is less characterized than creatine’s, and it has not been studied in GLP-1 users. Anyone considering it, especially someone with kidney concerns or other health conditions, should speak with a healthcare provider first.

 

 

Does metformin cause vitamin B12 deficiency?

Long-term metformin use is associated with lower vitamin B12 status in some people. In DPPOS, low B12 was reported in 4.3% of the metformin group at year 5, and combined low or borderline-low B12 was reported in 19.1%, both higher than placebo. Aroda et al. and the EMBER study describe population-level findings. They do not show that a supplement corrects B12 status for any individual.

If you take metformin, the reliable step is to ask your clinician about B12 testing and clinician-directed care rather than self-treating.

What is the difference between methylfolate and folic acid?

Folic acid is a synthetic folate form used in many supplements and fortified foods. L-methylfolate, or 5-MTHF, is a methylated folate form used in some supplements. Folate supports normal homocysteine metabolism.* Whether one form is more appropriate for you is an individualized question for your clinician, especially if you are monitoring folate or homocysteine.

How much creatine should you take, and is it safe for the kidneys?

A commonly used maintenance amount of creatine monohydrate in research is about 3 to 5 g per day, and a loading phase is not required. A 2025 systematic review and meta-analysis found no statistically significant pooled difference in GFR with creatine supplementation in the populations studied, while reporting a small increase in serum creatinine. Naeini et al. did not study this formula, GAA co-use, or GLP-1 users.

People with kidney disease, those using prescription medication, and anyone managing a health condition should confirm with their healthcare provider before starting creatine. General-population research does not automatically apply to every individual.

What should I ask my clinician about lean mass during GLP-1 treatment?

Start with the practical questions: Is my current nutrition plan realistic for my appetite and treatment goals? Is resistance training appropriate for me, and do I need help getting started or progressing safely? Would body-composition monitoring add useful context in my case, and if so, how should we interpret it? If I take metformin or have a history of low B12, should testing be part of the discussion?

You can also ask whether a supplement fits your individual medication list and health history. Bring the product label or Supplement Facts panel rather than relying on a general description. A productive clinical conversation is not about finding a shortcut. It is about putting training, nutrition, monitoring, and any supplement decision in the right order for you.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Safety and Tolerability

 

Creatine monohydrate has been studied extensively. A 2025 systematic review and meta-analysis found no statistically significant pooled difference in GFR in the populations studied, while reporting a small increase in serum creatinine. Naeini et al. concluded that the available findings did not show significant GFR change, but that does not establish safety for every individual, for GAA, for this finished formula, or during GLP-1 co-use.

GAA is less extensively characterized over the long term than creatine. In a six-week study of healthy recreationally active adults, creatine with or without GAA did not produce adverse changes in the clinical blood markers assessed. Babakhani et al. was short-term research in healthy adults, not evidence for people with health conditions or people using GLP-1 medication.

Talk to your healthcare provider before starting any supplement if you use prescription medication, have kidney disease or another health condition, or are pregnant or breastfeeding. This product is not intended for anyone under 18.

How to Use It

 

Take one scoop, about 10 g, once daily in cold water, following the product label. A loading phase is not required. Consistency matters more than timing, so choose a time that fits your routine.

Creatine is a complement to resistance training and adequate nutrition, not a substitute for either. If your clinician recommends body-composition monitoring, consistent measurement conditions and their interpretation of the results can provide context that a scale alone cannot.

What to Track Alongside Your Routine

Keep the routine simple enough to follow. You do not need to turn every workout or meal into a data project. A short training log can be useful for noting the exercises you perform, the resistance used, and whether your day-to-day strength or function feels stable, improving, or harder than expected. That information can be more meaningful to discuss with a clinician or qualified trainer than a single weigh-in.

Pay attention to tolerability, too. If you begin any supplement, note whether it fits your routine and whether you have questions about digestion, hydration, medication timing, or laboratory testing. Do not use changes in energy, body weight, or a single workout as proof of a product effect. GLP-1 treatment, calorie intake, sleep, stress, training progression, and health conditions can all affect how you feel from week to week.

If you notice a meaningful decline in strength or physical function, difficulty meeting nutrition needs, or questions about a body-composition report, bring those concerns to your healthcare provider. The goal is not to chase a perfect number. It is to make informed decisions that fit your medical plan, training capacity, and long-term health priorities.

The Healthcare Provider Perspective

 

Clinical discussions around GLP-1-supported weight management commonly focus on function and body composition as well as weight. Resistance training, individualized protein planning, and monitoring when appropriate are practical areas to discuss, with supplements considered case by case.

Creatine has a substantial research base in general populations, especially alongside training. The 2025 narrative review discusses creatine monohydrate in the GLP-1 context, but it does not replace direct clinical trials of creatine, GAA, or Creatine Reserve™ in GLP-1 users. Nothing in this article is a substitute for individualized medical advice.

A Consumer Decision Framework

 

Rather than telling you this is the best choice, here are useful questions to answer with your clinician:

·       Am I already training with resistance and working toward a protein plan that fits my needs?

·       Do I prefer plain creatine monohydrate, or do I prefer creatine, GAA, and selected B-vitamin forms in one scoop?

·       Do I take metformin, and have I discussed B12 testing?

·       Do I have kidney concerns, take prescription medication, or have another health condition that warrants medical review first?

Creatine Reserve™ may be worth discussing if you are pairing resistance training with GLP-1-supported weight management and prefer a single daily scoop that combines creatine, GAA, taurine, and the listed B-vitamin forms. It may be less relevant if you already prefer plain creatine monohydrate or do not want a multi-ingredient powder. Anyone with kidney disease or another condition that may affect supplement use should discuss options with a healthcare provider first.

The Bottom Line

 

GLP-1-supported weight management can be an opportunity to focus on body composition and function, not only body weight. Resistance training, individualized protein planning, and appropriate monitoring are the higher-priority conversations. Creatine has a substantial general evidence base for supporting muscle and exercise performance alongside training, and small studies have explored combining creatine with its precursor GAA.

Creatine Reserve™ combines creatine, GAA, taurine, and selected B-vitamin forms in one daily scoop. It has not been studied to preserve lean mass during GLP-1 therapy. The most informed way to decide whether it fits your plan is a conversation with your healthcare provider.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Learn More About Creatine Reserve™ →

Resources and References

 

Each entry notes what was tested and its main limit, so you can verify the source directly.

Aroda, V. R., et al. (2016). Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. Journal of Clinical Endocrinology & Metabolism, 101(4), 1754-1761. https://doi.org/10.1210/jc.2015-3754 | PubMed 26900641. Tested: B12 status in metformin and placebo groups over 5 and 13 years. Limit: Long-term follow-up data do not show that any supplement corrects an individual’s B12 status.

Babakhani, A., et al. (2025). Effects of six weeks of high-dose creatine monohydrate supplementation with or without guanidinoacetic acid on homocysteine and markers of health. Journal of the International Society of Sports Nutrition, 22(sup2), 2550207. https://doi.org/10.1080/15502783.2025.2550207 | Full text. Tested: Creatine monohydrate, 10 g per day, with or without GAA, 2 g per day, in 66 healthy adults for six weeks. Limit: Short-term marker data in healthy adults, not this formula, GLP-1 users, or a lean-mass study.

Chilibeck, P. D., et al. (2017). Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: A meta-analysis. Open Access Journal of Sports Medicine, 8, 213-226. https://doi.org/10.2147/OAJSM.S123529 | PubMed 29138605. Tested: 22 randomized trials involving 721 adults aged 57 to 70. Limit: General older adults, not GLP-1 users or a finished multi-ingredient product.

Johnson, B. V. B., Milstead, M., Kreider, R., & Jones, R. (2025). Dietary supplement considerations during glucagon-like peptide-1 receptor agonist treatment: A narrative review. Obesity Pillars. PubMed 41368199. Tested: Narrative synthesis of available literature. Limit: Not a direct clinical trial of creatine, GAA, or Creatine Reserve™ in GLP-1 users.

Naeini, E. K., et al. (2025). Effect of creatine supplementation on kidney function: A systematic review and meta-analysis. BMC Nephrology, 26, 622. https://doi.org/10.1186/s12882-025-04558-6 | PubMed 41199218. Tested: 21 studies; the meta-analysis found a small rise in serum creatinine and no statistically significant pooled GFR difference. Limit: General populations, not this formula or GLP-1 co-use.

Pashayee-Khamene, F., et al. (2024). Creatine supplementation protocols with or without training interventions on body composition: A GRADE-assessed systematic review and dose-response meta-analysis. Journal of the International Society of Sports Nutrition, 21(1), 2380058. https://doi.org/10.1080/15502783.2024.2380058 | PubMed 39042054. Tested: 143 randomized trials involving approximately 3,655 participants. Limit: Pooled general populations, not this formula or GLP-1 users.

Semeredi, S., et al. (2019). Guanidinoacetic acid with creatine compared with creatine alone for tissue creatine content, hyperhomocysteinemia, and exercise performance: A randomized, double-blind superiority trial. Nutrition, 57, 162-166. https://doi.org/10.1016/j.nut.2018.04.009 | PubMed 30170305. Tested: 1 g GAA plus 3 g creatine versus 4 g creatine in 14 healthy young men for four weeks. Limit: Small, short study in healthy young men, using a dose ratio different from this formula.

Wilding, J. P. H., et al. (2021). Impact of semaglutide on body composition in adults with overweight or obesity: Exploratory analysis of the STEP 1 study. Journal of the Endocrine Society, 5(Supplement 1), A16-A17. https://doi.org/10.1210/jendso/bvab048.030 | Full text. Tested: Body-composition change with semaglutide 2.4 mg in a DXA substudy of STEP 1. Limit: Subgroup data; DXA lean tissue is not equivalent to pure skeletal muscle and should not be generalized to every GLP-1 user.

Effect of Metformin Use on Vitamin B12 Deficiency Over Time, EMBER. (2023). Endocrine Practice, 29(11). PubMed 37611751. Tested: Real-world database association between metformin use and B12-deficiency laboratory results. Limit: Observational association, not causation or evidence that any supplement corrects individual B12 status.